Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on sleep in brain health

LIVE: Thursday 2nd May 2024, 18:00-19:30 (CEST)

Quality sleep is essential for health. But what happens to our brains when sleep patterns are disturbed? Join our experts to explore the interplay between sleep disruption and neurological diseases, and the questions that you need to be asking your patients to help you prevent the harmful effects of sleep deprivation.
ADVANCED SEARCH
Log in
Top
International Journal of Hematology
Published in: International Journal of Hematology 4/2007

01-11-2007

Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia: Study of the Japan Adult Leukemia Study Group (JALSG)

Authors: Shuichi Miyawaki, Yasukazu Kawai, Akihiro Takeshita, Norio Komatsu, Noriko Usui, Yukihiro Arai, Fumihiro Ishida, Takeshi Morii, Yasuhiko Kano, Michinori Ogura, Noriko Doki, Ryuzo Ohno

Published in: International Journal of Hematology | Issue 4/2007

Login to get access
Metadata
Title
Phase I Trial of FLAGM with High Doses of Cytosine Arabinoside for Relapsed, Refractory Acute Myeloid Leukemia: Study of the Japan Adult Leukemia Study Group (JALSG)
Authors
Shuichi Miyawaki
Yasukazu Kawai
Akihiro Takeshita
Norio Komatsu
Noriko Usui
Yukihiro Arai
Fumihiro Ishida
Takeshi Morii
Yasuhiko Kano
Michinori Ogura
Noriko Doki
Ryuzo Ohno
Publication date
01-11-2007
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 4/2007
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1532/IJH97.07072

Other articles of this Issue 4/2007

International Journal of Hematology 4/2007 Go to the issue

Letter To The Editor

Acute-Onset Pancytopenia in a Postpartum Lactating Woman

Letter to the editor

Bone Marrow Necrosis as a Terminal Complication of a Very Long-Lasting Polycythemia Vera

Case report

Splenic Peliosis in a Patient with Aplastic Anemia during Danazol Therapy

OriginalPaper

Activation of FKHRL1 Plays an Important Role in Protecting Erythroid Cells from Erythropoietin Deprivation-Induced Apoptosis in a Human Erythropoietin-Dependent Leukemia Cell Line, UT-7/EPO

OriginalPaper

High Frequency ofBCL2 Translocation in Thai Patients with Follicular Lymphomas

Case Report

Living-Donor Lobar Lung Transplantation for Broncho-Bronchiolitis Obliterans after Allogeneic Hematopoietic Stem Cell Transplantation: Does Bronchiolitis Obliterans Recur in Transplanted Lungs?
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits